Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The improvement in survival with chemotherapy has resulted in a change of the natural history of the systemic vasculitic syndromes. The vasculitides are now viewed as chronic disease rather than fatal conditions. Their course is frequently characterized by relapse as well as the scars of irreversible organ damage from disease and drug toxicity. Assessment tools are available which can serve as outcome measures in clinical trials as well as a guide to better management of individual patients. Improvements in therapy in future are dependent on a better understanding of the pathogenesis of these conditions and the ability to assess disease accurately.

Original publication

DOI

10.1016/s0950-3579(97)80052-0

Type

Journal article

Journal

Bailliere's clinical rheumatology

Publication Date

05/1997

Volume

11

Pages

423 - 446

Addresses

Department of Rheumatology, Western General Hospital, Edinburgh, UK.

Keywords

Animals, Humans, Vasculitis, Severity of Illness Index